Bavarian Nordic — April 2020
-
“With the rising cost of healthcare, patients and providers continue to look for effective and affordable ways to treat diabetes” commented Adam Steensberg, Executive Vice President of Research and Development, and Chief Medical Officer at Zealand Pharma.
-
-
Zealand Pharma opnår positive testresultater med nyindkøbt insulinpumpe
Efter en 14-dages test har Zealand Pharma opnået positive kliniske og økonomiske resultater med insulin-enheden V-Go. Firmaet håber nu på at udbydde enheden snarest muligt.
https://medwatch.dk/Medicinal___Biotek/article12078044.ece -
"This 14-week randomized, non-inferiority trial was conducted in a real-world practice setting under usual standard of care across three centers in the United States. Patients administering U-100 RAI analogs with V-Go
were randomly assigned to either continue RAI delivery by V-Go or switch to U-100 RHI." -
"The primary end-point was change in overall blood glucose levels (HbA1c), assessments of safety measures and insulin costs* were evaluated as secondary endpoints. For more information, visit https://www.clinicaltrials.gov/ct2/show/NCT01326598."
-
Du fyrer bare løs
-
Wearable Insulin Therapy A Safe Option for Adults with Type 2 Diabetes
Results from a study evaluating the safety of V-Go: https://www.drugtopics.com/latest/wearable-insulin-therapy-safe-option-adults-type-2-diabetes
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind